Applying its proprietary laboratory developed test for cfDNA, cfRNA and MSI liquid biopsies, CIRCULOGENE has developed a next-generation sequencing (NGS) method to provide full genomic load analysis from one standard tube of blood in one week, enabling more accurate data to help clinicians and their patients choose targeted therapies, monitor efficacy and monitor for recurrence. 

Biotechnology

CIRCULOGENE

CIRCULOGENE's headquarters in Birmingham, AL, United States

Mike Mullen

Lou Apicella

Travis Wold

Christy Roden Lee

Jonice Vanterpool Johnson

Chen-Hsiung Yeh

Richard B. Lanman

Stephen Eck

Paul Walker

Daniel Coleman

James Cantrell

The Commercial and Business Development Team at CIRCULOGENE focuses on expanding the market presence of the company's innovative liquid biopsy solutions. This team works to establish strategic partnerships, drive sales initiatives, and ensure exceptional client service, ultimately aiming to increase access to CIRCULOGENE's next-generation sequencing technology for healthcare providers and patients. They collaborate closely with sales, marketing, and operational teams to deliver targeted therapies and improve patient outcomes.

Commercial and Business Development Team

The Leadership Team at CIRCULOGENE is responsible for setting the strategic direction of the company, overseeing operational execution, and ensuring alignment across all departments to drive innovation in liquid biopsy technologies. They collaborate on business development, regulatory compliance, and market strategies to position CIRCULOGENE as a leader in genomic analysis, ultimately enhancing patient care through advanced diagnostic solutions.

Leadership Team

The Laboratory Operations Team at CIRCULOGENE oversees the execution and quality control of next-generation sequencing (NGS) processes for liquid biopsies. This team is responsible for optimizing laboratory protocols, ensuring compliance with industry regulations, and collaborating with clinical specialists to provide accurate genomic analyses that empower clinicians in selecting targeted therapies and monitoring patient outcomes. Through their expertise, they contribute to the innovation and efficiency of CIRCULOGENE's diagnostic advancements.

Laboratory Operations Team

The Clinical and Medical Team at CIRCULOGENE is responsible for overseeing the development and implementation of clinical studies to validate the efficacy of the company's liquid biopsy tests. This team collaborates closely with healthcare professionals to ensure evidence-based practices are utilized, providing insights that guide targeted therapy decisions and patient management. By integrating clinical expertise with advanced genomic technologies, they aim to enhance patient outcomes and streamline the application of CIRCULOGENE’s innovative testing methodologies in real-world settings.

Clinical and Medical Team

The Finance and Legal Team at CIRCULOGENE is responsible for ensuring the company's financial health and regulatory compliance. This includes managing budgeting, forecasting, financial reporting, and revenue generation, while also overseeing legal matters, risk management, and adherence to industry regulations. Their work supports CIRCULOGENE's mission by ensuring sound financial practices and legal safeguards that enable the development and distribution of innovative genomic testing solutions.

CIRCULOGENE

Org chart

Board & advisors

Teams

Commercial and Business Development Team

Leadership Team

Laboratory Operations Team

Clinical and Medical Team

Finance and Legal Team

Offices

CIRCULOGENE

Org chart

Board & advisors

Teams

Commercial and Business Development Team

Leadership Team

Laboratory Operations Team

Clinical and Medical Team

Finance and Legal Team

Offices

Related companies